Workforce shortage looms for U.S. medical device industry; Blockade Medical gains CE mark for coil system;

Medical Device News

@FierceMedDev: Roche Diagnostics plans to roll out a new interactive insulin pump system later this year. Article | Follow @FierceMedDev

 @MarkHFierce: What were the top 10 VC medical device deals in H1 2012? Report | Follow @MarkHFierce

> The U.S. medical device industry faces increasing problems in finding a well-qualified workforce to compete with emerging markets in China and India, according to a new study. Story

> Blockade Medical gained a CE mark for its Barricade coil system, which is designed to remove or endovascularly occlude blood flow in vascular abnormalities of the neurovascular and peripheral vessels. Release

> St. Jude Medical CEO Daniel Sparks believes the 2.3% device tax will propel more industry consolidation as well as other "unintended consequences," MassDevice reports. Story

> The Sacramento, CA region has a growing base of companies and industry partnerships focused on medical technology, the Sacramento Business Journal reports. Story (subs. req.)

> T2 Biosystems is making progress with a new hemostasis monitoring diagnostic product, which successfully monitored a number of blood-related factors on a single assay within minutes. Release

Biotech News

 @FierceBiotech: New compound nearly wipes out HIV in cells. More | Release | Follow @FierceBiotech

 @JohnCFierce: Sanofi/Regeneron enrolling 22,000 patients for Phase III PCSK9 program. Let the LDL games begin. Release | Follow @JohnCFierce

 @RyanMFierce: CHMP has backed approval of gene therapy for 1st time. How big of a 'first' is this in biotech business? Release | Follow @RyanMFierce

> Vivus shares drop amid speculation about IP threats to diet drug. More

> Sanofi and Roche race to PhIII with drugs aimed at hot PCSK9 gene. News

> Bristol-Myers loses to Onyx in PhIII battle of drugs for liver cancer. Article

> New biotech deals scrape record low as VC groups lose steam. Report

Pharma News

 @FiercePharma: Pfizer foils genericsmakers on Lyrica for 5 years. Last year's sales? $3.7B. Report | Follow @FiercePharma

 @EricPFierce: WSJ: J&J, feds reach deal of up to $2.2 billion; J&J to pay $400 million fine but keep selling to federal programs. Story | Follow @EricPFierce

> Did anemia drug giants game the system to rake in billions? Article

> Nacto may next attack Pfizer, Roche drugs with compulsory license. News

> Some docs not so hot on potential for diet drugs Qsymia, Belviq. More

> Pfizer foils genericsmakers on Lyrica for 5 years. Story

And Finally... Exactech ($EXAC) will partner with Conmed ($CNMD) to develop medical education programs that will advance the standard of care for patients facing shoulder and knee repair. Release

Suggested Articles

The ADDF announced its second round of research awards, with a total of $6 million in new funding for diagnostic tests.

Takeda teamed up with Enzyre to develop an at-home diagnostic device that will help people with hemophilia determine their own coagulation status.

Foundation Medicine received a diagnostic approval from the FDA for selecting HR+/HER2- breast cancer patients for treatment with Novartis' Piqray.